MX2018013562A - Metodo de produccion de una proteina recombinante. - Google Patents

Metodo de produccion de una proteina recombinante.

Info

Publication number
MX2018013562A
MX2018013562A MX2018013562A MX2018013562A MX2018013562A MX 2018013562 A MX2018013562 A MX 2018013562A MX 2018013562 A MX2018013562 A MX 2018013562A MX 2018013562 A MX2018013562 A MX 2018013562A MX 2018013562 A MX2018013562 A MX 2018013562A
Authority
MX
Mexico
Prior art keywords
recombinant protein
producing
recombinant
signal sequence
protein
Prior art date
Application number
MX2018013562A
Other languages
English (en)
Spanish (es)
Inventor
Peter Lewis Alan
Brian FINKA Gary
HOARE Michael
Uden Mark
Voulgaris Ioannis
Alexandra EMMINS Robyn
John Kenneth Lewis William
Daniel Mcinally Adam
Original Assignee
Glaxosmithkline Ip Dev Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Ip Dev Ltd filed Critical Glaxosmithkline Ip Dev Ltd
Publication of MX2018013562A publication Critical patent/MX2018013562A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/22—Vectors comprising a coding region that has been codon optimised for expression in a respective host

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
MX2018013562A 2016-05-06 2017-05-04 Metodo de produccion de una proteina recombinante. MX2018013562A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662332636P 2016-05-06 2016-05-06
US201662338045P 2016-05-18 2016-05-18
PCT/EP2017/060654 WO2017191255A1 (en) 2016-05-06 2017-05-04 Method of producing a recombinant protein

Publications (1)

Publication Number Publication Date
MX2018013562A true MX2018013562A (es) 2019-03-14

Family

ID=58765814

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018013562A MX2018013562A (es) 2016-05-06 2017-05-04 Metodo de produccion de una proteina recombinante.

Country Status (14)

Country Link
US (1) US11098312B2 (cg-RX-API-DMAC10.html)
EP (1) EP3452496A1 (cg-RX-API-DMAC10.html)
JP (2) JP2019516371A (cg-RX-API-DMAC10.html)
KR (1) KR102504317B1 (cg-RX-API-DMAC10.html)
CN (1) CN109071611B (cg-RX-API-DMAC10.html)
AU (1) AU2017260277A1 (cg-RX-API-DMAC10.html)
BR (1) BR112018072043A2 (cg-RX-API-DMAC10.html)
CA (1) CA3023025A1 (cg-RX-API-DMAC10.html)
IL (1) IL262544A (cg-RX-API-DMAC10.html)
MX (1) MX2018013562A (cg-RX-API-DMAC10.html)
RU (1) RU2742006C2 (cg-RX-API-DMAC10.html)
SG (1) SG11201808976WA (cg-RX-API-DMAC10.html)
TW (1) TWI794170B (cg-RX-API-DMAC10.html)
WO (1) WO2017191255A1 (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020165874A1 (en) * 2019-02-15 2020-08-20 Oncosimis Biotech Private Limited A bacterial expression vector for enhanced protein secretion
KR102094480B1 (ko) 2019-05-27 2020-04-01 (주)엘에스케이화인텍스 재사용 가능한 미세 먼지 항균 마스크
CN110551199B (zh) * 2019-09-26 2022-01-25 杭州纽龙日尚生物制品有限公司 一种提高工程菌分泌表达重组人表皮生长因子的方法
KR20240021234A (ko) 2021-06-10 2024-02-16 펠리칸 테크놀로지 홀딩스, 인크. 재조합 단백질 발현을 위한 박테리아 숙주

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1546342A2 (en) * 2002-09-20 2005-06-29 Cym1P A/S Methods for increasing the production of a recombinant polypeptide from a host cell
GB0426160D0 (en) * 2004-11-29 2004-12-29 Era Plantech S L Production of proteins
KR100981356B1 (ko) * 2006-01-31 2010-09-14 대한민국 신호서열 및 변이된 신호서열로 디자인된 분비증강자에의한 원래 형태의 수용성 재조합 단백질 생산 방법
GB0602173D0 (en) 2006-02-03 2006-03-15 Avecia Ltd Expression system
WO2009021548A1 (en) * 2007-08-10 2009-02-19 Wacker Chemie Ag Expression of full length igg and secretion into the culture medium of prokaryotic cells
RU2488635C1 (ru) * 2012-03-22 2013-07-27 Государственное бюджетное образовательное учреждение высшего профессионального образования Первый Московский государственный медицинский университет им. И.М. Сеченова Министерства здравоохранения и социального развития Российской Федерации (ГБОУ ВПО Первый МГМУ им. И.М. Сеченова Минздравсоцразвития Способ получения рекомбинантного антиангиогенного полипептида
US20140244228A1 (en) * 2012-09-19 2014-08-28 Agency For Science, Technology And Research Codon optimization of a synthetic gene(s) for protein expression

Also Published As

Publication number Publication date
US20190177734A1 (en) 2019-06-13
JP2019516371A (ja) 2019-06-20
SG11201808976WA (en) 2018-11-29
AU2017260277A1 (en) 2018-11-22
IL262544A (en) 2018-12-31
KR102504317B1 (ko) 2023-02-24
RU2742006C2 (ru) 2021-02-01
KR20190003694A (ko) 2019-01-09
BR112018072043A2 (pt) 2019-02-12
CN109071611B (zh) 2022-11-01
RU2018137305A (ru) 2020-06-08
US11098312B2 (en) 2021-08-24
CA3023025A1 (en) 2017-11-09
WO2017191255A1 (en) 2017-11-09
TW201805298A (zh) 2018-02-16
TWI794170B (zh) 2023-03-01
JP2022070902A (ja) 2022-05-13
RU2018137305A3 (cg-RX-API-DMAC10.html) 2020-06-08
CN109071611A (zh) 2018-12-21
EP3452496A1 (en) 2019-03-13

Similar Documents

Publication Publication Date Title
MX2025003310A (es) Integracion dirigida de acidos nucleicos
ZA202308519B (en) Anti-vegf protein compositions and methods for producing the same
MX2025004237A (es) Metodo de diferenciacion mejorada
MX2019002946A (es) Anticuerpos anti-pd-1 y sus usos.
WO2015191666A3 (en) Raf1 fusions
PH12018502456A1 (en) Anti-cd04 antibodies and their uses
MY198059A (en) Anti-ox40 antibodies and their uses
MX2018001497A (es) Proteinas de fusion de factor ix y metodos para producirlas y usarlas.
EP3009505A4 (en) Recombinant strain producing l-amino acids, constructing method therefor and method for producing l-amino acids.
MX2021001460A (es) Metodos y composiciones para secrecion de polipeptidos heterologos.
SG11202003614WA (en) Method for production of recombinant e. coli asparaginase
EP3101120A4 (en) Method for controlling galactosylation of recombinant protein through optimization of culture medium
PH12020500054A1 (en) Novel therapeutic enzyme fusion protein and use thereof
AU2015348922A8 (en) Codon optimized polynucleotide for high level expression of CRM197
MX2021005611A (es) Control de metales traza durante la produccion de anticuerpos anti-cd38.
MX2020005670A (es) Variantes de expresión de cdkl5 y proteínas de fusión de cdkl5.
MX2024000004A (es) Proteinas de fusion de inhibidor de tripsina urinaria (uti).
AU2017260277A1 (en) Method of producing a recombinant protein
WO2016068656A3 (ko) 사이코스 에퍼머화 효소의 발현 시스템 및 이를 이용한 사이코스의 생산
MX2017000014A (es) Metodo para producir acido graso de cadena media con el uso de beta-cetoacil-proteina portadora de acilo (acp) sintasa.
ZA202004214B (en) Method for producing 1,3-propylene glycol by means of fermentation of recombinant microorganism
SG10201806532RA (en) Proteins targeting orthologs
MX2015012300A (es) Procedimiento para la preparacion de 4-amino-1-(1s,4r,5s)-2-fluoro -4,5-dihidroxi-3-hidroximetil-ciclopent-2-enil)-1h-pirimidin-2-on a.
EP3623471A4 (en) RECOMBINANT MICRO-ORGANISM AND METHOD FOR THE PREPARATION OF PYRIDOXAMINE OR SALT THEREOF USING THE RECOMBINANT MICRO-ORGANISM